You are here

sNDA

Spectrum Pharma files Fusilev sNDA with FDA

Pharmaceutical Business Review

Tue, 01/4/11 - 10:06 am

Spectrum Pharmaceuticals

colorectal cancer

GlaxoSmithKline Withdraws Avodart US New Drug Application

WSJ Online

Mon, 11/23/09 - 09:53 am

prostate cancer

FDA To Review Takeda’s sNDA For Velcade

Pharmaceutical Business Review

Fri, 09/4/09 - 07:48 am

Multiple Myeloma

Lilly Resubmits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration

PR Newswire

Wed, 06/3/09 - 08:35 am

Spectrum Pharmaceuticals Announces That FDA Has Accepted FUSILEV sNDA for Colorectal Cancer Indication

Yahoo

Thu, 03/26/09 - 07:51 am

Spectrum Pharmaceuticals